aluates Reports

$ 0.0

Automative

Global Contraceptive Drugs and Devices Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-33Q9214

Global Contraceptive Drugs and Devices Market Insights Forecast to 2028

BUY CHAPTERS

Global Contraceptive Drugs and Devices Market Research Report 2025

Code: QYRE-Auto-33Q9214

Report

September 2025

Pages:82

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bayer HealthCare

Merck

Church Dwight

Warmer Chilcott

Agile Therapeutics

Pfizer Inc

BioSante Pharmaceuticals

Mayer Laboratories

Pantarhei Bioscience

Teva Pharmaceutical Industries

Contraceptive Drugs and Devices Market Size

The global market for Contraceptive Drugs and Devices was valued at US$ 7116 million in the year 2024 and is projected to reach a revised size of US$ 9594 million by 2031, growing at a CAGR of 4.4% during the forecast period.

Contraceptive Drugs and Devices Market

A contraceptive is a device or drug that prevents a woman from becoming pregnant.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Contraceptive Drugs and Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contraceptive Drugs and Devices.

The Contraceptive Drugs and Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Contraceptive Drugs and Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Contraceptive Drugs and Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Contraceptive Drugs and Devices Market Report

Report Metric	Details
Report Name	Contraceptive Drugs and Devices Market
Accounted market size in year	US$ 7116 million
Forecasted market size in 2031	US$ 9594 million
CAGR	4.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Oral Vaginal Injectable Contraceptive Drugs Male/Female Contraceptive Devices
Segment by Application	Hospitals Pharmacies Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Bayer Healthcare, Merck, Church & Dwight, Warmer Chilcott, Agile Therapeutics, Pfizer, BioSante Pharmaceuticals, Mayer Laboratories, Pantarhei Bioscience, Teva Pharmaceutical Industries
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Contraceptive Drugs and Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Contraceptive Drugs and Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Contraceptive Drugs and Devices Market growing?

Ans: The Contraceptive Drugs and Devices Market witnessing a CAGR of 4.4% during the forecast period 2025-2031.

What is the Contraceptive Drugs and Devices Market size in 2031?

Ans: The Contraceptive Drugs and Devices Market size in 2031 will be US$ 9594 million.

Who are the main players in the Contraceptive Drugs and Devices Market report?

Ans: The main players in the Contraceptive Drugs and Devices Market are Bayer Healthcare, Merck, Church & Dwight, Warmer Chilcott, Agile Therapeutics, Pfizer, BioSante Pharmaceuticals, Mayer Laboratories, Pantarhei Bioscience, Teva Pharmaceutical Industries

What are the Application segmentation covered in the Contraceptive Drugs and Devices Market report?

Ans: The Applications covered in the Contraceptive Drugs and Devices Market report are Hospitals, Pharmacies, Others

What are the Type segmentation covered in the Contraceptive Drugs and Devices Market report?

Ans: The Types covered in the Contraceptive Drugs and Devices Market report are Oral, Vaginal, Injectable Contraceptive Drugs, Male/Female Contraceptive Devices

1 Contraceptive Drugs and Devices Market Overview

1.1 Product Definition

1.2 Contraceptive Drugs and Devices by Type

1.2.1 Global Contraceptive Drugs and Devices Market Value Comparison by Type (2024 VS 2031)

1.2.2 Oral

1.2.3 Vaginal

1.2.4 Injectable Contraceptive Drugs

1.2.5 Male/Female Contraceptive Devices

1.3 Contraceptive Drugs and Devices by Application

1.3.1 Global Contraceptive Drugs and Devices Market Value by Application (2024 VS 2031)

1.3.2 Hospitals

1.3.3 Pharmacies

1.3.4 Others

1.4 Global Contraceptive Drugs and Devices Market Size Estimates and Forecasts

1.4.1 Global Contraceptive Drugs and Devices Revenue 2020-2031

1.4.2 Global Contraceptive Drugs and Devices Sales 2020-2031

1.4.3 Global Contraceptive Drugs and Devices Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Contraceptive Drugs and Devices Market Competition by Manufacturers

2.1 Global Contraceptive Drugs and Devices Sales Market Share by Manufacturers (2020-2025)

2.2 Global Contraceptive Drugs and Devices Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Contraceptive Drugs and Devices Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Contraceptive Drugs and Devices, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Contraceptive Drugs and Devices, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Contraceptive Drugs and Devices, Product Type & Application

2.7 Global Key Manufacturers of Contraceptive Drugs and Devices, Date of Enter into This Industry

2.8 Global Contraceptive Drugs and Devices Market Competitive Situation and Trends

2.8.1 Global Contraceptive Drugs and Devices Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Contraceptive Drugs and Devices Players Market Share by Revenue

2.8.3 Global Contraceptive Drugs and Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Contraceptive Drugs and Devices Market Scenario by Region

3.1 Global Contraceptive Drugs and Devices Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Contraceptive Drugs and Devices Sales by Region: 2020-2031

3.2.1 Global Contraceptive Drugs and Devices Sales by Region: 2020-2025

3.2.2 Global Contraceptive Drugs and Devices Sales by Region: 2026-2031

3.3 Global Contraceptive Drugs and Devices Revenue by Region: 2020-2031

3.3.1 Global Contraceptive Drugs and Devices Revenue by Region: 2020-2025

3.3.2 Global Contraceptive Drugs and Devices Revenue by Region: 2026-2031

3.4 North America Contraceptive Drugs and Devices Market Facts & Figures by Country

3.4.1 North America Contraceptive Drugs and Devices Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Contraceptive Drugs and Devices Sales by Country (2020-2031)

3.4.3 North America Contraceptive Drugs and Devices Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Contraceptive Drugs and Devices Market Facts & Figures by Country

3.5.1 Europe Contraceptive Drugs and Devices Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Contraceptive Drugs and Devices Sales by Country (2020-2031)

3.5.3 Europe Contraceptive Drugs and Devices Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Contraceptive Drugs and Devices Market Facts & Figures by Region

3.6.1 Asia Pacific Contraceptive Drugs and Devices Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Contraceptive Drugs and Devices Sales by Region (2020-2031)

3.6.3 Asia Pacific Contraceptive Drugs and Devices Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Contraceptive Drugs and Devices Market Facts & Figures by Country

3.7.1 Latin America Contraceptive Drugs and Devices Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Contraceptive Drugs and Devices Sales by Country (2020-2031)

3.7.3 Latin America Contraceptive Drugs and Devices Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Contraceptive Drugs and Devices Market Facts & Figures by Country

3.8.1 Middle East and Africa Contraceptive Drugs and Devices Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Contraceptive Drugs and Devices Sales by Country (2020-2031)

3.8.3 Middle East and Africa Contraceptive Drugs and Devices Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Contraceptive Drugs and Devices Sales by Type (2020-2031)

4.1.1 Global Contraceptive Drugs and Devices Sales by Type (2020-2025)

4.1.2 Global Contraceptive Drugs and Devices Sales by Type (2026-2031)

4.1.3 Global Contraceptive Drugs and Devices Sales Market Share by Type (2020-2031)

4.2 Global Contraceptive Drugs and Devices Revenue by Type (2020-2031)

4.2.1 Global Contraceptive Drugs and Devices Revenue by Type (2020-2025)

4.2.2 Global Contraceptive Drugs and Devices Revenue by Type (2026-2031)

4.2.3 Global Contraceptive Drugs and Devices Revenue Market Share by Type (2020-2031)

4.3 Global Contraceptive Drugs and Devices Price by Type (2020-2031)

5 Segment by Application

5.1 Global Contraceptive Drugs and Devices Sales by Application (2020-2031)

5.1.1 Global Contraceptive Drugs and Devices Sales by Application (2020-2025)

5.1.2 Global Contraceptive Drugs and Devices Sales by Application (2026-2031)

5.1.3 Global Contraceptive Drugs and Devices Sales Market Share by Application (2020-2031)

5.2 Global Contraceptive Drugs and Devices Revenue by Application (2020-2031)

5.2.1 Global Contraceptive Drugs and Devices Revenue by Application (2020-2025)

5.2.2 Global Contraceptive Drugs and Devices Revenue by Application (2026-2031)

5.2.3 Global Contraceptive Drugs and Devices Revenue Market Share by Application (2020-2031)

5.3 Global Contraceptive Drugs and Devices Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Bayer Healthcare

6.1.1 Bayer Healthcare Company Information

6.1.2 Bayer Healthcare Description and Business Overview

6.1.3 Bayer Healthcare Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Bayer Healthcare Contraceptive Drugs and Devices Product Portfolio

6.1.5 Bayer Healthcare Recent Developments/Updates

6.2 Merck

6.2.1 Merck Company Information

6.2.2 Merck Description and Business Overview

6.2.3 Merck Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Merck Contraceptive Drugs and Devices Product Portfolio

6.2.5 Merck Recent Developments/Updates

6.3 Church & Dwight

6.3.1 Church & Dwight Company Information

6.3.2 Church & Dwight Description and Business Overview

6.3.3 Church & Dwight Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Church & Dwight Contraceptive Drugs and Devices Product Portfolio

6.3.5 Church & Dwight Recent Developments/Updates

6.4 Warmer Chilcott

6.4.1 Warmer Chilcott Company Information

6.4.2 Warmer Chilcott Description and Business Overview

6.4.3 Warmer Chilcott Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Warmer Chilcott Contraceptive Drugs and Devices Product Portfolio

6.4.5 Warmer Chilcott Recent Developments/Updates

6.5 Agile Therapeutics

6.5.1 Agile Therapeutics Company Information

6.5.2 Agile Therapeutics Description and Business Overview

6.5.3 Agile Therapeutics Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Agile Therapeutics Contraceptive Drugs and Devices Product Portfolio

6.5.5 Agile Therapeutics Recent Developments/Updates

6.6 Pfizer

6.6.1 Pfizer Company Information

6.6.2 Pfizer Description and Business Overview

6.6.3 Pfizer Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Pfizer Contraceptive Drugs and Devices Product Portfolio

6.6.5 Pfizer Recent Developments/Updates

6.7 BioSante Pharmaceuticals

6.7.1 BioSante Pharmaceuticals Company Information

6.7.2 BioSante Pharmaceuticals Description and Business Overview

6.7.3 BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2020-2025)

6.7.4 BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Portfolio

6.7.5 BioSante Pharmaceuticals Recent Developments/Updates

6.8 Mayer Laboratories

6.8.1 Mayer Laboratories Company Information

6.8.2 Mayer Laboratories Description and Business Overview

6.8.3 Mayer Laboratories Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Mayer Laboratories Contraceptive Drugs and Devices Product Portfolio

6.8.5 Mayer Laboratories Recent Developments/Updates

6.9 Pantarhei Bioscience

6.9.1 Pantarhei Bioscience Company Information

6.9.2 Pantarhei Bioscience Description and Business Overview

6.9.3 Pantarhei Bioscience Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Pantarhei Bioscience Contraceptive Drugs and Devices Product Portfolio

6.9.5 Pantarhei Bioscience Recent Developments/Updates

6.10 Teva Pharmaceutical Industries

6.10.1 Teva Pharmaceutical Industries Company Information

6.10.2 Teva Pharmaceutical Industries Description and Business Overview

6.10.3 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Portfolio

6.10.5 Teva Pharmaceutical Industries Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Contraceptive Drugs and Devices Industry Chain Analysis

7.2 Contraceptive Drugs and Devices Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Contraceptive Drugs and Devices Production Mode & Process Analysis

7.4 Contraceptive Drugs and Devices Sales and Marketing

7.4.1 Contraceptive Drugs and Devices Sales Channels

7.4.2 Contraceptive Drugs and Devices Distributors

7.5 Contraceptive Drugs and Devices Customer Analysis

8 Contraceptive Drugs and Devices Market Dynamics

8.1 Contraceptive Drugs and Devices Industry Trends

8.2 Contraceptive Drugs and Devices Market Drivers

8.3 Contraceptive Drugs and Devices Market Challenges

8.4 Contraceptive Drugs and Devices Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Bayer HealthCare

Merck

Church Dwight

Warmer Chilcott

Agile Therapeutics

Pfizer Inc

BioSante Pharmaceuticals

Mayer Laboratories

Pantarhei Bioscience

Teva Pharmaceutical Industries

List of Tables

Table 1. Global Contraceptive Drugs and Devices Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Contraceptive Drugs and Devices Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Contraceptive Drugs and Devices Market Competitive Situation by Manufacturers in 2024

Table 4. Global Contraceptive Drugs and Devices Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Contraceptive Drugs and Devices Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Contraceptive Drugs and Devices Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Contraceptive Drugs and Devices Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Contraceptive Drugs and Devices Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Contraceptive Drugs and Devices, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Contraceptive Drugs and Devices, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Contraceptive Drugs and Devices, Product Type & Application

Table 12. Global Key Manufacturers of Contraceptive Drugs and Devices, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Contraceptive Drugs and Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contraceptive Drugs and Devices as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Contraceptive Drugs and Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Contraceptive Drugs and Devices Sales by Region (2020-2025) & (K Units)

Table 18. Global Contraceptive Drugs and Devices Sales Market Share by Region (2020-2025)

Table 19. Global Contraceptive Drugs and Devices Sales by Region (2026-2031) & (K Units)

Table 20. Global Contraceptive Drugs and Devices Sales Market Share by Region (2026-2031)

Table 21. Global Contraceptive Drugs and Devices Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Contraceptive Drugs and Devices Revenue Market Share by Region (2020-2025)

Table 23. Global Contraceptive Drugs and Devices Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Contraceptive Drugs and Devices Revenue Market Share by Region (2026-2031)

Table 25. North America Contraceptive Drugs and Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Contraceptive Drugs and Devices Sales by Country (2020-2025) & (K Units)

Table 27. North America Contraceptive Drugs and Devices Sales by Country (2026-2031) & (K Units)

Table 28. North America Contraceptive Drugs and Devices Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Contraceptive Drugs and Devices Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Contraceptive Drugs and Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Contraceptive Drugs and Devices Sales by Country (2020-2025) & (K Units)

Table 32. Europe Contraceptive Drugs and Devices Sales by Country (2026-2031) & (K Units)

Table 33. Europe Contraceptive Drugs and Devices Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Contraceptive Drugs and Devices Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Contraceptive Drugs and Devices Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Contraceptive Drugs and Devices Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Contraceptive Drugs and Devices Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Contraceptive Drugs and Devices Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Contraceptive Drugs and Devices Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Contraceptive Drugs and Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Contraceptive Drugs and Devices Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Contraceptive Drugs and Devices Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Contraceptive Drugs and Devices Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Contraceptive Drugs and Devices Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Contraceptive Drugs and Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Contraceptive Drugs and Devices Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Contraceptive Drugs and Devices Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Contraceptive Drugs and Devices Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Contraceptive Drugs and Devices Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Contraceptive Drugs and Devices Sales (K Units) by Type (2020-2025)

Table 51. Global Contraceptive Drugs and Devices Sales (K Units) by Type (2026-2031)

Table 52. Global Contraceptive Drugs and Devices Sales Market Share by Type (2020-2025)

Table 53. Global Contraceptive Drugs and Devices Sales Market Share by Type (2026-2031)

Table 54. Global Contraceptive Drugs and Devices Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Contraceptive Drugs and Devices Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Contraceptive Drugs and Devices Revenue Market Share by Type (2020-2025)

Table 57. Global Contraceptive Drugs and Devices Revenue Market Share by Type (2026-2031)

Table 58. Global Contraceptive Drugs and Devices Price (USD/Unit) by Type (2020-2025)

Table 59. Global Contraceptive Drugs and Devices Price (USD/Unit) by Type (2026-2031)

Table 60. Global Contraceptive Drugs and Devices Sales (K Units) by Application (2020-2025)

Table 61. Global Contraceptive Drugs and Devices Sales (K Units) by Application (2026-2031)

Table 62. Global Contraceptive Drugs and Devices Sales Market Share by Application (2020-2025)

Table 63. Global Contraceptive Drugs and Devices Sales Market Share by Application (2026-2031)

Table 64. Global Contraceptive Drugs and Devices Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Contraceptive Drugs and Devices Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Contraceptive Drugs and Devices Revenue Market Share by Application (2020-2025)

Table 67. Global Contraceptive Drugs and Devices Revenue Market Share by Application (2026-2031)

Table 68. Global Contraceptive Drugs and Devices Price (USD/Unit) by Application (2020-2025)

Table 69. Global Contraceptive Drugs and Devices Price (USD/Unit) by Application (2026-2031)

Table 70. Bayer Healthcare Company Information

Table 71. Bayer Healthcare Description and Business Overview

Table 72. Bayer Healthcare Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Bayer Healthcare Contraceptive Drugs and Devices Product

Table 74. Bayer Healthcare Recent Developments/Updates

Table 75. Merck Company Information

Table 76. Merck Description and Business Overview

Table 77. Merck Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Merck Contraceptive Drugs and Devices Product

Table 79. Merck Recent Developments/Updates

Table 80. Church & Dwight Company Information

Table 81. Church & Dwight Description and Business Overview

Table 82. Church & Dwight Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Church & Dwight Contraceptive Drugs and Devices Product

Table 84. Church & Dwight Recent Developments/Updates

Table 85. Warmer Chilcott Company Information

Table 86. Warmer Chilcott Description and Business Overview

Table 87. Warmer Chilcott Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Warmer Chilcott Contraceptive Drugs and Devices Product

Table 89. Warmer Chilcott Recent Developments/Updates

Table 90. Agile Therapeutics Company Information

Table 91. Agile Therapeutics Description and Business Overview

Table 92. Agile Therapeutics Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Agile Therapeutics Contraceptive Drugs and Devices Product

Table 94. Agile Therapeutics Recent Developments/Updates

Table 95. Pfizer Company Information

Table 96. Pfizer Description and Business Overview

Table 97. Pfizer Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Pfizer Contraceptive Drugs and Devices Product

Table 99. Pfizer Recent Developments/Updates

Table 100. BioSante Pharmaceuticals Company Information

Table 101. BioSante Pharmaceuticals Description and Business Overview

Table 102. BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. BioSante Pharmaceuticals Contraceptive Drugs and Devices Product

Table 104. BioSante Pharmaceuticals Recent Developments/Updates

Table 105. Mayer Laboratories Company Information

Table 106. Mayer Laboratories Description and Business Overview

Table 107. Mayer Laboratories Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Mayer Laboratories Contraceptive Drugs and Devices Product

Table 109. Mayer Laboratories Recent Developments/Updates

Table 110. Pantarhei Bioscience Company Information

Table 111. Pantarhei Bioscience Description and Business Overview

Table 112. Pantarhei Bioscience Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Pantarhei Bioscience Contraceptive Drugs and Devices Product

Table 114. Pantarhei Bioscience Recent Developments/Updates

Table 115. Teva Pharmaceutical Industries Company Information

Table 116. Teva Pharmaceutical Industries Description and Business Overview

Table 117. Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product

Table 119. Teva Pharmaceutical Industries Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Contraceptive Drugs and Devices Distributors List

Table 123. Contraceptive Drugs and Devices Customers List

Table 124. Contraceptive Drugs and Devices Market Trends

Table 125. Contraceptive Drugs and Devices Market Drivers

Table 126. Contraceptive Drugs and Devices Market Challenges

Table 127. Contraceptive Drugs and Devices Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Contraceptive Drugs and Devices

Figure 2. Global Contraceptive Drugs and Devices Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Contraceptive Drugs and Devices Market Share by Type: 2024 & 2031

Figure 4. Oral Product Picture

Figure 5. Vaginal Product Picture

Figure 6. Injectable Contraceptive Drugs Product Picture

Figure 7. Male/Female Contraceptive Devices Product Picture

Figure 8. Global Contraceptive Drugs and Devices Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Contraceptive Drugs and Devices Market Share by Application: 2024 & 2031

Figure 10. Hospitals

Figure 11. Pharmacies

Figure 12. Others

Figure 13. Global Contraceptive Drugs and Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Contraceptive Drugs and Devices Market Size (2020-2031) & (US$ Million)

Figure 15. Global Contraceptive Drugs and Devices Sales (2020-2031) & (K Units)

Figure 16. Global Contraceptive Drugs and Devices Average Price (USD/Unit) & (2020-2031)

Figure 17. Contraceptive Drugs and Devices Report Years Considered

Figure 18. Contraceptive Drugs and Devices Sales Share by Manufacturers in 2024

Figure 19. Global Contraceptive Drugs and Devices Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Contraceptive Drugs and Devices Players: Market Share by Revenue in Contraceptive Drugs and Devices in 2024

Figure 21. Contraceptive Drugs and Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Contraceptive Drugs and Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Contraceptive Drugs and Devices Sales Market Share by Country (2020-2031)

Figure 24. North America Contraceptive Drugs and Devices Revenue Market Share by Country (2020-2031)

Figure 25. U.S. Contraceptive Drugs and Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Contraceptive Drugs and Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Contraceptive Drugs and Devices Sales Market Share by Country (2020-2031)

Figure 28. Europe Contraceptive Drugs and Devices Revenue Market Share by Country (2020-2031)

Figure 29. Germany Contraceptive Drugs and Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Contraceptive Drugs and Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Contraceptive Drugs and Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Contraceptive Drugs and Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Contraceptive Drugs and Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Contraceptive Drugs and Devices Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Contraceptive Drugs and Devices Revenue Market Share by Region (2020-2031)

Figure 36. China Contraceptive Drugs and Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Contraceptive Drugs and Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Contraceptive Drugs and Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Contraceptive Drugs and Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Contraceptive Drugs and Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Taiwan Contraceptive Drugs and Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Indonesia Contraceptive Drugs and Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Thailand Contraceptive Drugs and Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Malaysia Contraceptive Drugs and Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Philippines Contraceptive Drugs and Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America Contraceptive Drugs and Devices Sales Market Share by Country (2020-2031)

Figure 47. Latin America Contraceptive Drugs and Devices Revenue Market Share by Country (2020-2031)

Figure 48. Mexico Contraceptive Drugs and Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil Contraceptive Drugs and Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina Contraceptive Drugs and Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Middle East and Africa Contraceptive Drugs and Devices Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Contraceptive Drugs and Devices Revenue Market Share by Country (2020-2031)

Figure 53. Turkey Contraceptive Drugs and Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Contraceptive Drugs and Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. U.A.E Contraceptive Drugs and Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Global Sales Market Share of Contraceptive Drugs and Devices by Type (2020-2031)

Figure 57. Global Revenue Market Share of Contraceptive Drugs and Devices by Type (2020-2031)

Figure 58. Global Contraceptive Drugs and Devices Price (USD/Unit) by Type (2020-2031)

Figure 59. Global Sales Market Share of Contraceptive Drugs and Devices by Application (2020-2031)

Figure 60. Global Revenue Market Share of Contraceptive Drugs and Devices by Application (2020-2031)

Figure 61. Global Contraceptive Drugs and Devices Price (USD/Unit) by Application (2020-2031)

Figure 62. Contraceptive Drugs and Devices Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

RELATED REPORTS

Global Foetal Skull Model Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8G20187

Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Anatomy Set Pregnancy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30J19782

Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Global Embryo Model Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-39D19945

Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Global Prostate Model Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-25M19897

Sat Nov 22 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions